Courses

Journal CME 41.01: Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease

On Demand Journal CME

60 Minutes

Experienced / Intermediate

CME Credits:1.00

1074<p>The Journal CME 41.01 article aims to investigate cross-sectional and longitudinal associations between baseline cerebrospinal fluid (CSF) PENK concentration and regional brain atrophy, compared identified patterns with CSF neurofilament light (NfL), and evaluated PENK and NfL for discriminating between HD Integrated Staging System (HD-ISS) stage 0 versus 1 in a far-from-onset HD gene-expanded (HDGE) cohort.</p>Biomarkers, Biomarkers & Diagnostic Tools, Chorea/Huntingtons Disease (HD), Hyperkinetic Movement DisordersMena Farag, MBBS, MRCP601.00https://education.movementdisorders.org/Detail/1074/Journal-CME-41-01:-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntington's-Diseasehttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2026-02-11T00:00:002027-02-11T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.01%20-%20Disclosures_06022026033938.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the biological rationale for CSF proenkephalin as a striatum-specific biomarker in Huntington&rsquo;s disease<br>2. Assess associations between baseline CSF PENK and longitudinal regional brain atrophy compared with neurofilament light<br>3. Evaluate the role of CSF PENK in distinguishing early HD-ISS stages and its potential value for clinical trial enrichment<br><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-41.01-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntingtons-Disease.htmJournal CME 41.01: Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's DiseaseJournal CME 41.012026-02-11T12:01:11.93000Experienced / IntermediateClinicianFellowIndustryResearcherResidentJournal CMECMEEnglishOn-DemandUSA

TWSTRS: Toronto-Western Spasmodic Torticollis Rating Scale Training

On Demand COA / Rating Scale Trainings

90 Minutes

COA Certificate

920<p>The video demonstrates the 10 categories in the TWSTRS scale, with verbal and visual examples of scoring in each category.</p><br /><p>Comella, C.L., Stebbins, G.T., Goetz, C.G., Chmura, T.A., Bressman, S.B. and Lang, A.E. (1997), Teaching tape for the motor section of the toronto western spasmodic torticollis scale. Mov. Disord., 12: 570-575. <a href="https://doi.org/10.1002/mds.870120414 " target="_blank">https://doi.org/10.1002/mds.870120414&nbsp;</a><br /></p>Biomarkers & Diagnostic Tools, Dystonia, Hyperkinetic Movement Disorders, Rating ScalesC.L. Comella900.00https://education.movementdisorders.org/Detail/920/TWSTRS:-Toronto-Western-Spasmodic-Torticollis-Rating-Scale-Traininghttps://education.movementdisorders.org/Upload/ActivityImages/COA-training-LMS699655.jpg2022-12-31T00:00:002028-12-31T00:00:00<p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.<br>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)<br>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher<br>4. Adobe Flash Player 12.0 (or higher).<br>5. Adobe Reader to print certificate.</p><p><strong>Faculty</strong></p><p>Cynthia L. Comella, MD - Rush University Medical Center, Chicago, IL, USA</p><p>Glenn T. Stebbins, PhD - Rush University Medical Center, Chicago, IL, USA</p><p>Teresa A. Chmura, BS - Rush University Medical Center, Chicago, IL, USA</p><p>Christopher G. Goetz, MD - Rush University Medical Center, Chicago, IL, USA</p><p>Susan B. Bressman, MD - Icahn School of Medicine at Mount Sinai, New York, NY, USA</p><p>Anthony E. Lang, MD, FRCPC - Toronto Western Hospital, Toronto, ON, Canada</p>MDS Clinical Outcome Assessments Program0/Courses/TWSTRS-Toronto-Western-Spasmodic-Torticollis-Rating-Scale-Training.htmTWSTRS: Toronto-Western Spasmodic Torticollis Rating Scale Training2026-01-21T15:00:50.01300COA / Rating Scale TrainingsCOA CertificateEnglishOn-DemandUSA

Journal CME 40.12: Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial

On Demand Journal CME

60 Minutes

Experienced / Intermediate

CME Credits:1.00

1064<p>The Journal CME 40.12 article aims to evaluate the effects of a probiotic (Lacticaseibacillus rhamnosus, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Enterococcus faecium) on gut microbiota, inflammation, motor and non-motor symptoms (NMS) in PwP and constipation.</p>Etiology & Pathophysiology, Microbiome, Nutritional Therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-OtherValentina Leta, PhD601.00https://education.movementdisorders.org/Detail/1064/Journal-CME-40-12:-Effects-of-a-Four-Strain-Probiotic-on-Gut-Microbiota,-Inflammation,-and-Symptoms-in-Parkinson's-Disease:-A-Randomized-Clinical-Trialhttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-12-18T00:00:002026-12-18T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.12%20-%20Disclosures_17122025024322.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p><span style="color: rgb(0, 0, 0);">1. Understand the role of gut dysbiosis in Parkinson&rsquo;s disease</span></p><p><span style="color: rgb(0, 0, 0);">2. Assess the impact of a four-strain probiotic on microbiota, inflammation, and symptoms</span></p><p><span style="color: rgb(0, 0, 0);">3. Evaluate the clinical value of probiotics as an adjunct therapy in Parkinson&rsquo;s disease</span></p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.12-Effects-of-a-Four-Strain-Probiotic-on-Gut-Microbiota-Inflammation-and-Symptoms-in-Parkinsons-Disease-A-Randomized-Clinical-Trial.htmJournal CME 40.12: Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical TrialJournal CME 40.122025-12-18T15:01:04.61700Experienced / IntermediateClinicianFellowIndustryResearcherResidentJournal CMECMEEnglishOn-DemandUSA

Journal CME 40.11: Waveform-Based Analysis of Head Tremor Using a Marker-Less Tracking Algorithm with 2D-Video: Evaluation of Sinusoidality and Rhythmicity

On Demand Journal CME

60 Minutes

Experienced / Intermediate

CME Credits:1.00

1059<p>The Journal CME 40.11 article aims to introduce a novel video-based waveform analysis to objectively measure two fundamental tremor characteristics&mdash;rhythmicity and sinusoidality.</p>Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Rating Scales, Tremor/Essential Tremor (ET)Jung Hwan Shin, MD, PhD601.00https://education.movementdisorders.org/Detail/1059/Journal-CME-40-11:-Waveform-Based-Analysis-of-Head-Tremor-Using-a-Marker-Less-Tracking-Algorithm-with-2D-Video:-Evaluation-of-Sinusoidality-and-Rhythmicityhttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-11-26T00:00:002026-11-26T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.11%20-%20Disclosures_25112025025555.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of rhythmicity and sinusoidality in differentiating tremor types using video-based waveform analysis</p><p>2. Assess the reliability of video-based indices in measuring tremor characteristics by comparing them to gyroscope-based data</p><p>3. Evaluate the effectiveness of video-based analysis in distinguishing between cervical dystonia and essential tremor based on rhythmicity and sinusoidality indices</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.11-Waveform-Based-Analysis-of-Head-Tremor-Using-a-Marker-Less-Tracking-Algorithm-with-2D-Video-Evaluation-of-Sinusoidality-and-Rhythmicity.htmJournal CME 40.11: Waveform-Based Analysis of Head Tremor Using a Marker-Less Tracking Algorithm with 2D-Video: Evaluation of Sinusoidality and RhythmicityJournal CME 40.112025-11-26T12:01:08.62700Experienced / IntermediateClinicianFellowIndustryResearcherResidentJournal CMECMEEnglishOn-DemandUSA

MDS Case Presentation: Hyperkinetic Disorder in a 9 Year-Old Boy

On Demand Case Presentation Series

15 Minutes

Foundational / Beginner

941This brief 15 minute case presentation will provide the learner with an opportunity to accept the role of a decisive clinician regarding a clinical case of a 9 year-old patient with hyperkinetic disorder.Basal Ganglia, Biomarkers, Biomarkers & Diagnostic Tools, Deep brain stimulation, Dystonia, Etiology & Pathophysiology, Genetics, Hyperkinetic Movement Disorders, Medications for motor symptoms, Medications for non-motor symptoms, Neuroimaging, Neuropathology, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Rating Scales, Therapies-Pharmacological, Therapies-SurgicalAlia Mansour, PhD150.00https://education.movementdisorders.org/Detail/941/MDS-Case-Presentation:-Hyperkinetic-Disorder-in-a-9-Year-Old-Boyhttps://education.movementdisorders.org/Upload/ActivityImages/Case-based-Series866197.jpg2025-11-18T00:00:002028-11-18T00:00:00MDS Education<p><strong>FACULTY</strong></p><p>Alia Mansour, PhD - Ain Shams University, Cairo, Egypt</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Develop a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/MDS-Case-Presentation-Hyperkinetic-Disorder-in-a-9-Year-Old-Boy.htmMDS Case Presentation: Hyperkinetic Disorder in a 9 Year-Old Boy2025-11-18T09:00:51.45000Foundational / BeginnerClinicianClinician-Primary CareFellowHealth ProfessionalIndustryResidentStudentCase Presentation SeriesEnglishOn-DemandUSA

Diagnosis and Management of Motor Symptoms in Early Parkinson's Disease

On Demand Interactive

60 Minutes

Foundational / Beginner

CME Credits:1.00

1047<p>This module will explore the clinical diagnostic criteria for Parkinson&rsquo;s Disease (PD) with emphasis on early stage motor symptoms, as well as exploring atypical presentations and potential differentials. Treatment of early PD motor symptoms will be discussed using the evidence basis for approved therapies.</p>Biomarkers, Biomarkers & Diagnostic Tools, Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Etiology & Pathophysiology, Genetics, Lewy-body dementia (LBD), Medications for motor symptoms, Multiple Systems Atrophy (MSA), Neuroimaging, Neuropathology, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Rating Scales, Therapies-Pharmacological601.00https://education.movementdisorders.org/Detail/1047/Diagnosis-and-Management-of-Motor-Symptoms-in-Early-Parkinson's-Diseasehttps://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-44-001--Motor-Symptoms-in-Early-PD-202x108552477.jpghttps://education.movementdisorders.org/Upload/BannerImages/05INTERACT-44-001--Motor-Symptoms-in-Early-PD-734x404583314.jpg2025-11-06T00:00:002028-11-06T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Disclosures - Early PD_20102025113733.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION&nbsp;</strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>FACULTY</strong></p><p>Rob de Bie, MD, PhD - Amsterdam University Medical Center, Amsterdam, Netherlands</p><p>Monty Silverdale, MD, PhD - Manchester Centre for Clinical Neurosciences, Salford, United Kingdom</p><p>Ai Huey Tan, MD, PhD, FRCP - University of Malaya, Kuala Lumpur, Malaysia</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><p>1. Obtain a good clinical history from a patient presenting with parkinsonian features.</p><p>2. Identify typical and atypical features in clinical examination of a patient presenting with parkinsonian features.</p><p>3. Develop a step-by-step approach in making a diagnosis of Parkinson&rsquo;s disease based on the MDS Clinical Diagnostic Criteria.</p><p>4. Outline a treatment plan for managing motor symptoms in early Parkinson&rsquo;s disease based on available clinical evidence.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Diagnosis-and-Management-of-Motor-Symptoms-in-Early-Parkinsons-Disease.htmDiagnosis and Management of Motor Symptoms in Early Parkinson's Disease2025-11-06T15:01:05.57000Foundational / BeginnerClinicianFellowIndustryResidentStudentInteractiveCMEEnglishOn-DemandUSA

Journal CME 40.10: Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson’s Disease: A Longitudinal Multi-Cohort Study

On Demand Journal CME

60 Minutes

Experienced / Intermediate

CME Credits:1.00

1046<p>The Journal CME 40.10 article aims to evaluate the utility of polygenic scores (PGSs) for cognitive reserve proxies, including intelligence (INT), educational attainment (EA), and occupational attainment (OA), in predicting the clinical progression of PD.</p>Anxiety/Depression, Autonomic Dysfunction, Cognitive impairment/Dementia, Etiology & Pathophysiology, Genetics, Impulse Control Disorders, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Psychosis, Sensory disorders, Sleep Disorders, Speech DisordersYoung Eun Huh, MD, PhD601.00https://education.movementdisorders.org/Detail/1046/Journal-CME-40-10:-Protective-Effects-of-Genetic-Proxies-of-Cognitive-Reserve-in-Parkinson’s-Disease:-A-Longitudinal-Multi-Cohort-Studyhttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-10-06T00:00:002026-10-06T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.10%20-%20Disclosures_01102025093927.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of cognitive reserve and its genetic proxies in influencing the progression of Parkinson&rsquo;s disease</p><p>2. Assess the predictive value of polygenic scores for intelligence, educational attainment, and occupational attainment in clinical outcomes of PD</p><p>3. Evaluate how genetic markers of cognitive reserve can inform prognosis and contribute to personalized management strategies in PD</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.10-Protective-Effects-of-Genetic-Proxies-of-Cognitive-Reserve-in-Parkinsons-Disease-A-Longitudinal-Multi-Cohort-Study.htmJournal CME 40.10: Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson’s Disease: A Longitudinal Multi-Cohort StudyJournal CME 40.102025-10-06T18:01:04.39700Experienced / IntermediateClinicianFellowIndustryResearcherResidentJournal CMECMEEnglishOn-DemandUSA

Journal CME 40.09: Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder

On Demand Journal CME

60 Minutes

Foundational / Beginner

CME Credits:1.00

1044<p>The Journal CME 40.09 article reports multicenter clinical (Expanded Disability Scoring Scale [EDSS]), neurocognitive), neuroimaging (Sundal score), and biological (neurofilament light chain [NfL]) outcomes after HSCT in CSF1R-RD.</p>Genetic & Hereditary Disorders, Infusion therapy, Other Movement Disorders, Therapies-SurgicalHemmo A.F. Yska, MD601.00https://education.movementdisorders.org/Detail/1044/Journal-CME-40-09:-Hematopoietic-Stem-Cell-Transplantation-in-an-International-Cohort-of-Colony-Stimulating-Factor-1-Receptor-(CSF1R)-Related-Disorderhttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-09-24T00:00:002026-09-24T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.09%20-%20Disclosures_16092025021345.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the clinical rationale and early outcomes of HSCT in CSF1R-RD patients</p><p>2. Assess the significance of neuroimaging and biomarker changes post-HSCT</p><p>3. Evaluate the potential benefits and limitations of reduced-intensity conditioning in CSF1R-RD treatment</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.09-Hematopoietic-Stem-Cell-Transplantation-in-an-International-Cohort-of-Colony-Stimulating-Factor-1-Receptor-CSF1R-Related-Disorder.htmJournal CME 40.09: Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related DisorderJournal CME 40.092025-09-24T09:01:10.52300Foundational / BeginnerClinicianFellowIndustryResearcherResidentStudentJournal CMECMEEnglishOn-DemandUSA

Journal CME 40.08:Cholinergic System Changes in Dopa-Unresponsive Freezing of Gait in Parkinson’s Disease

On Demand Journal CME

60 Minutes

Foundational / Beginner

CME Credits:1.00

1029<p>The Journal CME 40.08 article aims to investigate whether specific cholinergic system changes are associated with FoG responsiveness to levodopa treatment in PD patients.</p>Basic/Translational Neuroscience, Dopaminergic medications, Etiology & Pathophysiology, Medications for motor complications, Medications for motor symptoms, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-PharmacologicalKelvin L. Chou, MD601.00https://education.movementdisorders.org/Detail/1029/Journal-CME-40-08:Cholinergic-System-Changes-in-Dopa-Unresponsive-Freezing-of-Gait-in-Parkinson’s-Diseasehttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-09-24T00:00:002026-09-24T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.08%20-%20Disclosure%20Template_22082025020404.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of cholinergic system degeneration in the development and progression of freezing of gait (FoG) in PD</p><p>2. Evaluate the differences in brain cholinergic activity between patients with levodopa-responsive and levodopa-unresponsive FoG based on VAChT PET imaging findings</p><p>3. Assess how extra-striatal cholinergic deficits may contribute to resistance to levodopa treatment in FoG</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.08Cholinergic-System-Changes-in-Dopa-Unresponsive-Freezing-of-Gait-in-Parkinsons-Disease.htmJournal CME 40.08:Cholinergic System Changes in Dopa-Unresponsive Freezing of Gait in Parkinson’s DiseaseJournal CME 40.082025-09-24T09:01:02.21000Foundational / BeginnerClinicianFellowIndustryResearcherResidentStudentJournal CMECMEEnglishOn-DemandUSA

Essentials of Device-Assisted Therapies in Parkinson's Disease: Programming a patient with DBS - Conventional STN and GPI, Neurophysiology guided, and Imaging guided programming

On Demand Device Aided Medical Therapies

30 Minutes

Foundational / Beginner

CME Credits:0.50

1038<p>This module will cover programming a patient with DBS from fundamental principles to patient-specific considerations and safety precautions, troubleshooting strategies and optimizing therapeutic outcomes.&nbsp;</p>Deep brain stimulation, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-SurgicalDrew Kern, MD, MS300.50https://education.movementdisorders.org/Detail/1038/Essentials-of-Device-Assisted-Therapies-in-Parkinson's-Disease:-Programming-a-patient-with-DBS---Conventional-STN-and-GPI,-Neurophysiology-guided,-and-Imaging-guided-programming--https://education.movementdisorders.org/Upload/ActivityImages/10766771.jpg2025-09-18T00:00:002028-09-18T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.5&nbsp;<em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/DAT%20Module%2010%20-%20Disclosures_12092025033214.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION&nbsp;</strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p><p><br></p>MDS Education<p><strong>FACULTY</strong></p><p>Drew Kern, MD, MS - University of Colorado, Aurora, Colorado, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity learners will be able to:</p><p>1. Demonstrate the adjustment of stimulation parameters. &nbsp;</p><p>2. Identify and minimize common adverse effects by optimizing the parameters.&nbsp;</p><p>3. Implement troubleshooting strategies to address suboptimal therapeutic outcomes.&nbsp;</p><p>4. Use of neurophysiology-based and image guided programming in DBS.</p><p><br></p><p><strong>ABOUT THE ESSENTIALS OF DEVICE ASSISTED THERAPIES SERIES</strong></p><p>The MDS Essentials of Device-Assisted Therapies in Parkinson&#39;s Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson&#39;s Disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.</p><p><br></p><p><strong>HOW TO TRANSLATE THIS MODULE</strong></p><p>For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false">&nbsp;<video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/How To Translate - DAMT_15092025053301.mp4" type="video/mp4">&nbsp;Your browser does not support HTML5 video.</video>&nbsp;</span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Mozilla Firefox or Google Chrome.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Essentials-of-Device-Assisted-Therapies-in-Parkinsons-Disease-Programming-a-patient-with-DBS---Conventional-STN-and-GPI-Neurophysiology-guided-and-Imaging-guided-programming.htmEssentials of Device-Assisted Therapies in Parkinson's Disease: Programming a patient with DBS - Conventional STN and GPI, Neurophysiology guided, and Imaging guided programming2025-09-18T12:01:08.64700Foundational / BeginnerClinicianFellowIndustryResidentStudentDevice Aided Medical TherapiesCMEEnglishOn-DemandUSA